| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/22/2004 | US20040141989 polypeptides comprising segments of prostate gland proteins and to DNA codes for such polypeptides used in vaccines for prophylaxis of tumors |
| 07/22/2004 | US20040141988 Tumour-specific animal proteins |
| 07/22/2004 | US20040141986 Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose |
| 07/22/2004 | US20040141985 Biossay for measuring the release of interferons from lymphocytes; inoculation against infection by mycobacterium by administering CD8 epitopes capable of inhibiting the binding of the epitopes to lymphocyte receptors |
| 07/22/2004 | US20040141984 Amyloid beta 1-6 antigen arrays |
| 07/22/2004 | US20040141983 Compositions against cancer antigen LIV-1 and uses thereof |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/22/2004 | US20040141981 administering biological conjugates comprising chlorotoxin sensitive cytoplasmic proteins, used for the screening and prophylaxis of cancer |
| 07/22/2004 | US20040141975 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 07/22/2004 | US20040141973 IPG antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141958 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte |
| 07/22/2004 | US20040141952 Death domain containing receptor 5 |
| 07/22/2004 | US20040141950 Immunostimulatory combinations |
| 07/22/2004 | US20040141944 polymer synthesized by a cross-coupling reaction of polymer scaffold units and xenoantigens |
| 07/22/2004 | US20040141918 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | CA2551760A1 Antimicrobial composition for local use on mucosal membranes and skin |
| 07/22/2004 | CA2512735A1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | CA2512138A1 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | CA2511966A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 07/22/2004 | CA2511907A1 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | CA2511838A1 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | CA2511823A1 Combination therapy with co-stimulatory factors |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | CA2511538A1 Immunostimulatory combinations |
| 07/22/2004 | CA2511513A1 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | CA2511512A1 Immunogenic compositions containing phospholipid |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1439184A1 Immunological adjuvant compounds |
| 07/21/2004 | EP1438970A2 Methods for inhibiting HIV associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells |
| 07/21/2004 | EP1438969A1 Arterivirus marker vaccine |
| 07/21/2004 | EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite |
| 07/21/2004 | EP1438583A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/21/2004 | EP1438402A2 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/21/2004 | EP1438388A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 07/21/2004 | EP1438386A2 Transmembrane protein differentially expressed in cancer |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438339A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438334A2 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 07/21/2004 | EP1438323A2 Adjuvanted meningococcus compositions |
| 07/21/2004 | EP1438299A1 Bifunctional chelating agent for actinium |
| 07/21/2004 | EP1438077A1 Methods of sterilizing biological materials containing non-aqueous solvents |
| 07/21/2004 | EP1438074A2 Adjuvant compositions |
| 07/21/2004 | EP1438070A1 Treating vascular disease by inhibiting toll-like receptor-4 |
| 07/21/2004 | EP1438068A2 Antibody inhibitors of gdf-8 and uses thereof |
| 07/21/2004 | EP1438067A1 Autologous growth factor cocktail composition, method of production and use |
| 07/21/2004 | EP1438066A1 Incapacitated whole-cell immunogenic bacterial compositions |
| 07/21/2004 | EP1438057A2 Pine cone extracts and uses thereof |
| 07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
| 07/21/2004 | EP0635030B1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS |
| 07/21/2004 | CN1514879A Moraxella (branhamella) catarrhalis antigens |
| 07/21/2004 | CN1514736A Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/21/2004 | CN1513996A Marek's disease virus vaccine CV1988 strain VP22 gene |
| 07/21/2004 | CN1513995A Pleiomorphic saccharomyces hansenii expression recombination cholere toxin B subunit gene and its application |
| 07/21/2004 | CN1513987A Recombination pseudorabies virus for expressing pig breeding and respiration comproehensive oyndrome virus and application |
| 07/21/2004 | CN1513874A Human source anti SARS coronavirus gene engineering antibody |
| 07/21/2004 | CN1513556A Recombination human Mucl-MBP fusion protein antitumour vaccine and production technology |
| 07/21/2004 | CN1513555A Hepatitis A-B combined vaccine and its freeze dried preparation |
| 07/21/2004 | CN1513554A Animal rabies virus suggarl mucleorrotein divalent DNA vaccine |
| 07/21/2004 | CN1513553A Vero cell fick-borne encephalitis inactivated vaccine |
| 07/21/2004 | CN1513552A Lung tissue endochylema bacteria (Sacheromyces globosus) series vaccine and diagnoses agent and production method |
| 07/21/2004 | CN1513551A Compound biological preparation composition and its preparation method |
| 07/21/2004 | CN1158387C Chimeric gene encoding antigenic determinants of four proteins of L.INFANTUM |
| 07/20/2004 | US6765091 Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them |
| 07/20/2004 | US6765088 Immunological detection of prions |
| 07/20/2004 | US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression |
| 07/20/2004 | US6764838 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/20/2004 | US6764835 Saturation mutageneis in directed evolution |
| 07/20/2004 | US6764834 For diagnosis, prophylaxis, therapy |
| 07/20/2004 | US6764689 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 07/20/2004 | US6764687 Live attenuated bacteria for use in a vaccine |
| 07/20/2004 | US6764685 Chimeric viruses; cdna or rna used to express heterologous gene products in host cell systems and/or to rescue negative strand rna recombinant viruses |
| 07/20/2004 | US6764684 Avian herpesvirus-based recombinant infectious bursal disease vaccine |
| 07/20/2004 | US6764682 Adjuvant compositions containing more than one adjuvant |
| 07/20/2004 | US6764680 Administering monoclonal antibodies |
| 07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 07/20/2004 | US6764676 Attenuated fiv-141 virus with deletion mutation in the env gene; vaccines; replicates upon entry to host cell |
| 07/20/2004 | CA2253374C Novel osp-c derived peptide fragments |
| 07/20/2004 | CA2103148C Determination of motifs of peptides on mhc molecules |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/20/2004 | CA2042640C Barbiturate assay, tracers, immunogens, antibodies and kit |
| 07/15/2004 | WO2004059318A2 Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation |
| 07/15/2004 | WO2004059285A2 Tumor killing/tumor regression using cxcr4 antagonists |
| 07/15/2004 | WO2004059278A2 Methods of screening for anti-inflammatory drugs and use thereof |
| 07/15/2004 | WO2004058968A1 Purification of recombinant filamental bacteriophages by means of affinity chromatography to increase the immunogenicity and efficacy of phagic vaccines |
| 07/15/2004 | WO2004058808A2 Dna vaccines against hantavirus infections |
| 07/15/2004 | WO2004058806A2 Inclusion bodies as antigens for the oral vaccination of animals against csfv |
| 07/15/2004 | WO2004058801A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/15/2004 | WO2004058799A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 07/15/2004 | WO2004058299A1 Vaccine comprising polynucleotide |
| 07/15/2004 | WO2004058297A1 Combinations of growth- and hormone-regulating factors for the treatment of neoplasia |
| 07/15/2004 | WO2004058292A2 Methods and compositions for suppressing fibrocyte differentiation |
| 07/15/2004 | WO2004058278A1 Recombinant vaccine viruses expressing il-15 and methods of using the same |
| 07/15/2004 | WO2004058191A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |